The replay of this event will be emailed to all ticket holders the day after the event.
The last several years have witnessed an unprecedented explosion of knowledge acquisition related to lymphatic diseases, encompassing primary and secondary lymphedema, lymphatic and complex malformations, and lipedema, among many other related topics. There is much that is new and exciting in this field.
Please join Stanford University and LE&RN in the 2024 Virtual Lymphatic Summit—Lymphatic Disease 2024: What’s New? What’s Exciting to understand the evolving knowledge base in the broad domain of biomedical research, encompassing bioengineering; imaging and intervention; genetics and gene therapy; diet, pharmacology and surgery; and role of lymphatics in the expression of systemic health and disease. The Summit will feature the presentations of the global leaders in these fields.
Up to 10 million Americans are estimated to be living with lymphedema (LE) and there are an additional 17 million women in America estimated to have lipedema (LI). The World Health Organization projects up to 250 million people with LE worldwide. Nevertheless, lymphatic patients still struggle to find physicians who are prepared to undertake their necessary medical care. Upon completion of this summit, participants will be better equipped to provide state-of-the-art lymphatic care.
Stanley G. Rockson, MD
Summit Organizer Chief of Consultative Cardiology, Allan and Tina Neill Professor of Lymphatic Research and Medicine Professor of Medicine, Director, Center for Lymphatic and Venous Disorders Stanford University School of Medicine, Falk Cardiovascular Research Center
Stanley G. Rockson, Stanford University and LE&RN
William Repicci, President and CEO, LE&RN